Mad Money

Cramer's lightning round: Hims & Hers Health is not a buy

Key Points
  • It's that time again! "Mad Money" host Jim Cramer rings the lightning round bell, which means he's giving his answers to callers' stock questions at rapid speed.

Loading chart...

Hims & Hers Health Inc: "Hims & Hers lose money ... I'm not recommending stocks that are losing a lot of money."

Loading chart...

Two Harbors Investment Corp: "I'm not going there. We've seen a lot of companies like that. ... I'm not playing."

Loading chart...

Shell Midstream Partners LP: "[Enterprise Product Partners], that's the best one if you want to be in that group now."

Loading chart...

Healthcare Realty Trust Inc: "I thought [the company's merger with Healthcare Trust of America] made a lot of sense. ... I like it."

Loading chart...

DraftKings Inc: "[Kynikos Associates founder] Jim Chanos says it's a great short. I think the time to short the stock was much, much higher."

Loading chart...

Gilead Sciences Inc: "I know it looks very, very cheap. But you know what, that's not why we buy drugs stocks. We buy drug stocks because they've got growth, and Gilead has none."

VIDEO4:2804:28
Cramer's lightning round: Hims & Hers Health is not a buy

Sign up now for the CNBC Investing Club to follow Jim Cramer's every move in the market.

Disclaimer

Questions for Cramer?
Call Cramer: 1-800-743-CNBC

Want to take a deep dive into Cramer's world? Hit him up!
Mad Money Twitter - Jim Cramer Twitter - Facebook - Instagram

Questions, comments, suggestions for the "Mad Money" website? madcap@cnbc.com